TY  - JOUR
AU  - Wiendl, Heinz
AU  - Carraro, Matthew
AU  - Comi, Giancarlo
AU  - Izquierdo, Guillermo
AU  - Kim, Ho Jin
AU  - Sharrack, Basil
AU  - Tornatore, Carlo
AU  - Daizadeh, Nadia
AU  - Chung, Luke
AU  - Jacobs, Alan K
AU  - Hogan, Richard J
AU  - Wychowski, Linda V
AU  - Van Wijmeersch, Bart
AU  - CARE-MS I, CARE-MS II, and CAMMS03409 Investigators
PY  - 2019
DO  - 10.1212/NXI.0000000000000635
UR  - http://hdl.handle.net/10668/15511
T2  - Neurology(R) neuroimmunology & neuroinflammation
AB  - To examine the association between peripheral blood lymphocyte pharmacodynamics and autoimmune adverse events (AEs) or return of disease activity in alemtuzumab-treated patients with relapsing-remitting MS. Patients received 2 alemtuzumab courses (12...
LA  - en
KW  - Adolescent
KW  - Adult
KW  - Alemtuzumab
KW  - Autoimmune Diseases
KW  - Female
KW  - Humans
KW  - Immunologic Factors
KW  - Kidney Diseases
KW  - Lymphocyte Count
KW  - Lymphocytes
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - Recurrence
KW  - Thrombocytopenia
KW  - Thyroid Diseases
KW  - Young Adult
TI  - Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab.
TY  - research article
VL  - 7
ER  -